##analysisDate=2017-06-28-11-03-59000
##analyzedBy=RingStudy Site E
##exportDate=2017-11-08-12-48-36000
##analysisName=Sample 3-PHASE1
##workflowName=Oncomine Focus w2.1 - DNA and Fusions - Single Sample
##sampleNames=Site E-R1-Sample 3-F-D_v1:Site E-R5-Sample 3-F-R_RNA_v1
##reference=hg19
##variantGroup=DEFAULT
##filterChain=Site D_NoRef
##searchText=
##chromosome=All
##totalVariantCount=892
##filterInCount=42
##filteredOutCount=850
##hiddenVariantCount=0
Locus	Genotype	Ref	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Detection	3'/5' Imbalance	COSMIC/NCBI	Read Counts Per Million	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	Gene Ontology	DrugBank	ClinVar	p-value	Phred QUAL Score	Allele Coverage	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles
chr1:11188179	A/AG	A	INDEL		MTOR	exonic	1								15.81	p.Leu1972fs		1974	A=0.8419, AG=0.1581		Present				-	43	NM_004958.3	c.5914_5915insC	frameshiftInsertion	2.21				FAT domain,FATC domain,Phosphatidylinositol 3- and 4-kinase								ATP binding,Golgi apparatus,Golgi membrane,PML body,RNA polymerase III type 1 promoter DNA binding,RNA polymerase III type 2 promoter DNA binding,RNA polymerase III type 3 promoter DNA binding,T cell costimulation,TFIIIC-class transcription factor binding,TOR signaling cascade,TORC1 complex,TORC2 complex,cell growth,cellular response to hypoxia,cellular response to nutrient levels,cytoplasm,cytosol,dendrite,endomembrane system,endoplasmic reticulum,endoplasmic reticulum membrane,fibroblast growth factor receptor signaling pathway,germ cell development,growth,insulin receptor signaling pathway,kinase activity,lysosome,mTOR-FKBP12-rapamycin complex,membrane,mitochondrial outer membrane,mitochondrion,negative regulation of NFAT protein import into nucleus,negative regulation of autophagy,negative regulation of cell size,negative regulation of macroautophagy,nerve growth factor receptor signaling pathway,neuronal cell body,nucleotide binding,nucleus,peptidyl-serine phosphorylation,peptidyl-threonine phosphorylation,phosphatidylinositol 3-kinase complex,phosphatidylinositol-mediated signaling,phosphoprotein binding,phosphorylation,phosphotransferase activity, alcohol group as acceptor,positive regulation of actin filament polymerization,positive regulation of endothelial cell proliferation,positive regulation of lamellipodium assembly,positive regulation of lipid biosynthetic process,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of protein kinase B signaling cascade,positive regulation of protein phosphorylation,positive regulation of stress fiber assembly,positive regulation of transcription from RNA polymerase III promoter,positive regulation of translation,protein autophosphorylation,protein binding,protein catabolic process,protein domain specific binding,protein phosphorylation,protein serine/threonine kinase activity,regulation of Rac GTPase activity,regulation of actin cytoskeleton organization,regulation of carbohydrate metabolic process,regulation of carbohydrate utilization,regulation of fatty acid beta-oxidation,regulation of glycogen biosynthetic process,regulation of protein kinase activity,regulation of response to food,response to amino acid stimulus,response to insulin stimulus,response to nutrient,ribosome binding,ruffle organization,signal transduction,soluble fraction	Everolimus,Pimecrolimus,Sirolimus,Temsirolimus		0.00001	249.291	A=1662, AG=312		A=806/856, AG=115/197	3	
chr1:65310489	C/G	T	SNV		JAK1	exonic, exonic	1								C=75.68, G=24.32	p.(=), p.(=)		1838	T=0.0, C=0.7568, G=0.2432		Present				-	16	NM_002227.2, NM_002227.2	c.2199A>G, c.2199A>C	synonymous, synonymous	-4.13				Protein kinase domain,Protein tyrosine kinase	rs2230588		0.352 (ref)	0.2323	0.418	0.3492	YES	ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile		0.00001	23896.5	T=0, C=1391, G=447		T=0/0, C=919/472, G=146/301	1,1	
chr1:65312342	G/A	G	SNV		JAK1	exonic	1								80.78	p.(=)		1998	G=0.1922, A=0.8078		Present				-	14	NM_002227.2	c.1977C>T	synonymous	-2.0				Protein kinase domain,Protein tyrosine kinase	rs17127063		0.053 (ref)	0.027	0.1076	0.054	YES	ATP binding,cytokine-mediated signaling pathway,cytoplasm,cytoskeleton,cytosol,endomembrane system,growth hormone receptor binding,interferon-gamma-mediated signaling pathway,intracellular protein kinase cascade,intracellular signal transduction,membrane,non-membrane spanning protein tyrosine kinase activity,nucleotide binding,nucleus,protein binding,protein phosphorylation,protein tyrosine kinase activity,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,response to antibiotic,type I interferon-mediated signaling pathway	2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZH-IMIDAZ4,5-FISOQUINOLIN-7-ONE,3-{(3R,4R)-4-methyl-3-methyl(7H-pyrrolo2,3-dpyrimidin-4-yl)aminopiperidin-1-yl}-3-oxopropanenitrile		0.00001	17651.7	G=384, A=1614		G=213/171, A=1012/602	1	
chr1:115252195	T/TG	T	INDEL		NRAS	exonic	1								10.15	p.Arg149fs		1783	T=0.8985, TG=0.1015		Present				-	4	NM_002524.4	c.444_445insC	frameshiftInsertion	0.4				Miro-like protein,Ras family								GTP binding,GTPase activity,Golgi apparatus,Golgi membrane,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,actin cytoskeleton organization,activation of MAPKK activity,axon guidance,blood coagulation,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane fraction,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of Rac protein signal transduction,positive regulation of cell proliferation,regulation of long-term neuronal synaptic plasticity,regulation of synaptic transmission, GABAergic,signal transduction,small GTPase mediated signal transduction,striated muscle cell differentiation,visual learning			0.00019	37.1129	T=1602, TG=181		T=896/706, TG=51/130	2	
chr1:115252225	T/TC	T	INDEL		NRAS	exonic	1								11.94	p.Ile139fs		1809	T=0.8806, TC=0.1194		Present				-	4	NM_002524.4	c.414_415insG	frameshiftInsertion	2.18				Miro-like protein,Ras family								GTP binding,GTPase activity,Golgi apparatus,Golgi membrane,MAPKKK cascade,Ral guanyl-nucleotide exchange factor activity,Ras protein signal transduction,actin cytoskeleton organization,activation of MAPKK activity,axon guidance,blood coagulation,epidermal growth factor receptor signaling pathway,insulin receptor signaling pathway,leukocyte migration,membrane fraction,nerve growth factor receptor signaling pathway,nucleotide binding,plasma membrane,positive regulation of Rac protein signal transduction,positive regulation of cell proliferation,regulation of long-term neuronal synaptic plasticity,regulation of synaptic transmission, GABAergic,signal transduction,small GTPase mediated signal transduction,striated muscle cell differentiation,visual learning			0.00001	90.7934	T=1593, TC=216		T=785/808, TC=143/73	3	
chr1:156834532, chr1:156851323			ASSAYS_5P_3P		NTRK1								NTRK1.5p.eNST00000392302.e2e3,NTRK1.3p.eNST00000392302.e17e18				91,971				NoCall	0.0033		3.3633e-10,3.5888e-09																						0.0					
chr2:29416176	A/AG	A	INDEL		ALK	exonic	1								15.46	p.Glu1594fs		951	A=0.8454, AG=0.1546		Present				-	29	NM_004304.4	c.4776_4777insC	frameshiftInsertion	-0.89				MAM domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	94.4027	A=804, AG=147		A=403/401, AG=18/129	3	
chr2:29416366	C/C	G	SNV		ALK	exonic	1								100.00	p.Asp1529Glu		1988	G=0.0, C=1.0		Present				-	29	NM_004304.4	c.4587C>G	missense	-1.46	1.0	45.0	0.0	MAM domain,Protein kinase domain,Protein tyrosine kinase	rs1881421		0.435 (ref)	0.3438	0.3915	0.4335	YES	ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	26704.1	G=0, C=1988		G=0/0, C=933/1055	1	
chr2:29416572	C/C	T	SNV		ALK	exonic	1								100.00	p.Ile1461Val		1992	T=0.0, C=1.0		Present				-	29	NM_004304.4	c.4381A>G	missense	-0.25	1.0	29.0	0.0	MAM domain,Protein kinase domain,Protein tyrosine kinase	rs1670283		0.007 (ref)	3.0E-4	0.0279	0.0097		ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	26870.5	T=0, C=1992		T=0/0, C=947/1045	1	
chr2:29416630	T/TG	T	INDEL		ALK	exonic	1								G=0.00, TG=10.78	p.Pro1442fs		1938	T=0.8922, G=0.0, TG=0.1078		Present				-	29	NM_004304.4	c.4322_4323insC	frameshiftInsertion	-2.25				MAM domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	209.327	T=1729, G=0, TG=209		T=783/946, G=0/0, TG=76/133	1,4	
chr2:29445458	G/T	G	SNV		ALK	exonic	1								17.26	p.(=)		1564	G=0.8274, T=0.1726		Present				-	21	NM_004304.4	c.3375C>A	synonymous	-1.83				MAM domain,Protein kinase domain,Protein tyrosine kinase	rs3795850		0.395 (ref)	0.2058	0.2519	0.2214	YES	ATP binding,NF-kappaB-inducing kinase activity,activation of MAPK activity,cell proliferation,integral to plasma membrane,neuron development,nucleotide binding,phosphorylation,plasma membrane,positive regulation of NF-kappaB transcription factor activity,protein autophosphorylation,receptor activity,regulation of apoptotic process,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	796.79	G=1294, T=270		G=637/657, T=130/140	1	
chr2:29551347, chr2:29430138			ASSAYS_5P_3P		ALK								ALK.5p_NM_004304.4.e5e6,ALK.3p_NM_004304.4.e23e24				2865,221				Absent, LOW_5P_3P_IMBALANCE_SCORE	-0.01		1.0589e-08,8.1680e-10																						0.0					
chr3:178916901	A/AC	A	INDEL		PIK3CA	exonic	1								10.35	p.Phe98fs		1865	A=0.8965, AC=0.1035		Present				+	2	NM_006218.2	c.291_292insC	frameshiftInsertion	2.09				PI3-kinase family,Phosphatidylinositol 3- and 4-kinase,Phosphoinositide 3-kinase C2,Phosphoinositide 3-kinase family								1-phosphatidylinositol-3-kinase activity,ATP binding,T cell costimulation,T cell receptor signaling pathway,angiogenesis,anti-apoptosis,blood coagulation,cytosol,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,glucose metabolic process,hypomethylation of CpG island,insulin receptor signaling pathway,insulin receptor substrate binding,kinase activity,lamellipodium,leukocyte migration,nerve growth factor receptor signaling pathway,nucleotide binding,phosphatidylinositol 3-kinase complex,phosphatidylinositol phosphorylation,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,phosphatidylinositol-mediated signaling,phosphotransferase activity, alcohol group as acceptor,platelet activation,positive regulation of peptidyl-serine phosphorylation,protein binding,protein kinase B signaling cascade,protein kinase activator activity,protein phosphorylation,protein serine/threonine kinase activity,regulation of multicellular organism growth,signal transduction	(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-(METHYLOXY)METHYL-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO4,3,2-DEINDENO4,5-H2BENZOPYRAN-11-YL ACETATE		0.00015	38.3554	A=1672, AC=193		A=723/949, AC=167/26	3	
chr4:1807849	C/CG	C	INDEL		FGFR3	exonic	1								13.15	p.Leu638fs		1247	C=0.8685, CG=0.1315		Present				+	14	NM_000142.4	c.1911_1912insG	frameshiftInsertion	-1.23				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs104886005							ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib		0.00001	80.4793	C=1083, CG=164		C=720/363, CG=26/138	3	
chr4:1807894	A/A	G	SNV		FGFR3	exonic	1								100.00	p.(=)		1252	G=0.0, A=1.0		Present				+	14	NM_000142.4	c.1953G>A	synonymous	0.05				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs7688609		0.042 (ref)	8.0E-4	0.131	0.0449	YES	ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib		0.00001	16817.4	G=0, A=1252		G=0/0, A=715/537	1	
chr4:1808387	G/GC	G	INDEL		FGFR3	exonic	1								24.08	p.Ala717fs		1989	G=0.7592, GC=0.2408		Present				+	16	NM_000142.4	c.2148_2149insC	frameshiftInsertion	2.21				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,JAK-STAT cascade,MAPKKK cascade,bone maturation,bone morphogenesis,chondrocyte differentiation,chondrocyte proliferation,cytoplasmic membrane-bounded vesicle,endochondral bone growth,endochondral ossification,endoplasmic reticulum,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,focal adhesion,insulin receptor signaling pathway,integral to plasma membrane,negative regulation of developmental growth,nucleotide binding,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phospholipase activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,protein autophosphorylation,protein binding,protein tyrosine kinase activity,receptor activity,regulation of apoptotic process,skeletal system development	Palifermin,Pazopanib		0.00001	1003.32	G=1510, GC=479		G=694/816, GC=403/76	3	
chr4:55133741	A/AC	A	INDEL		PDGFRA	exonic	1								9.11	p.Thr320fs		1965	A=0.9089, AC=0.0911		Present				+	7	NM_006206.4	c.957_958insC	frameshiftInsertion	-1.01				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing	Becaplermin,Imatinib,Pazopanib,Sunitinib		0.00107	29.722	A=1786, AC=179		A=1058/728, AC=52/127	3	
chr4:55141055	G/G	A	SNV		PDGFRA	exonic	1								100.00	p.(=)		1995	A=0.0, G=1.0		Present				+	12	NM_006206.4	c.1701A>G	synonymous	-5.31				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs121913270,rs121913271,rs1873778		0.037 (ref)	0.0015	0.1185	0.0411	YES	ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing	Becaplermin,Imatinib,Pazopanib,Sunitinib		0.00001	26856.9	A=0, G=1995		A=0/0, G=1065/930	1	
chr4:55144175	T/TG	T	INDEL		PDGFRA	splicesite_3	1								16.26			1986	T=0.8374, TG=0.1626		Present				+	14	NM_006206.4			2.23				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,Leydig cell differentiation,adrenal gland development,cardiac myofibril assembly,cell activation,cell chemotaxis,cellular response to amino acid stimulus,cytoplasm,elevation of cytosolic calcium ion concentration,embryonic cranial skeleton morphogenesis,embryonic digestive tract morphogenesis,embryonic skeletal system morphogenesis,estrogen metabolic process,extracellular matrix organization,face morphogenesis,female gonad development,gliogenesis,growth factor binding,in utero embryonic development,inner ear development,integral to plasma membrane,intrinsic to plasma membrane,lung development,luteinization,male genitalia development,metanephric glomerular capillary formation,multicellular organismal development,negative regulation of platelet activation,nucleotide binding,nucleus,odontogenesis of dentin-containing tooth,palate development,peptidyl-tyrosine phosphorylation,phosphatidylinositol 3-kinase binding,phosphatidylinositol-mediated signaling,plasma membrane,platelet aggregation,platelet-derived growth factor alpha-receptor activity,platelet-derived growth factor binding,platelet-derived growth factor receptor binding,platelet-derived growth factor receptor signaling pathway,platelet-derived growth factor receptor-alpha signaling pathway,positive regulation of DNA replication,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,protein autophosphorylation,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,regulation of actin cytoskeleton reorganization,regulation of chemotaxis,regulation of mesenchymal stem cell differentiation,response to cytokine stimulus,response to estradiol stimulus,response to hormone stimulus,response to hyperoxia,response to inorganic substance,retina vasculature development in camera-type eye,signal transduction involved in regulation of gene expression,transmembrane receptor protein tyrosine kinase activity,vascular endothelial growth factor receptor signaling pathway,vascular endothelial growth factor-activated receptor activity,wound healing	Becaplermin,Imatinib,Pazopanib,Sunitinib		0.00001	209.563	T=1663, TG=323		T=812/851, TG=43/280	3	
chr4:55592166	T/TG	T	INDEL		KIT	exonic	1								21.12	p.Lys499fs		1979	T=0.7888, TG=0.2112		Present				+	9	NM_000222.2	c.1493_1494insG	frameshiftInsertion	1.07				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs67271072							ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway	Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib		0.00001	478.971	T=1561, TG=418		T=1004/557, TG=59/359	3	
chr4:55593686	T/TC	T	INDEL		KIT	exonic	1								18.54	p.Arg586fs		1980	T=0.8146, TC=0.1854		Present				+	11	NM_000222.2	c.1755_1756insC	frameshiftInsertion	0.2				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway	Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib		0.00001	497.499	T=1613, TC=367		T=591/1022, TC=286/81	3	
chr4:55594203	G/GC	G	INDEL		KIT	exonic	1								16.16	p.Leu637fs		1986	G=0.8384, GC=0.1616		Present				+	13	NM_000222.2	c.1909_1910insC	frameshiftInsertion	2.88				Immunoglobulin I-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,activation of MAPK activity,cytokine binding,cytokine-mediated signaling pathway,cytoplasm,external side of plasma membrane,extracellular space,germ cell programmed cell death,glycosphingolipid metabolic process,hemopoiesis,integral to membrane,intracellular protein kinase cascade,lymphoid progenitor cell differentiation,male gonad development,mast cell differentiation,mast cell proliferation,melanocyte differentiation,metal ion binding,myeloid progenitor cell differentiation,negative regulation of programmed cell death,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of JAK-STAT cascade,positive regulation of MAPKKK cascade,positive regulation of gene expression,positive regulation of phosphatidylinositol 3-kinase activity,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of sequence-specific DNA binding transcription factor activity,positive regulation of tyrosine phosphorylation of Stat1 protein,positive regulation of tyrosine phosphorylation of Stat3 protein,positive regulation of tyrosine phosphorylation of Stat5 protein,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,regulation of developmental pigmentation,response to radiation,signal transduction,spermatid development,spermatogenesis,stem cell factor receptor activity,stem cell maintenance,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway	Adenosine-5'-Diphosphate,Dasatinib,Imatinib,Nilotinib,Pazopanib,Phosphonotyrosine,Sorafenib,Sunitinib		0.00001	233.896	G=1665, GC=321		G=900/765, GC=255/66	3	
chr5:112175568	G/GC	G	INDEL		APC	exonic	1								15.36	p.Gly1428fs		1966	G=0.8464, GC=0.1536		Present				+	16	NM_000038.5	c.4280_4281insC	frameshiftInsertion	2.88				APC 15 residue motif,APC basic domain,APC cysteine-rich region,Armadillo/beta-catenin-like repeat,EB-1 Binding Domain,SAMP Motif								APC-Axin-1-beta-catenin complex,Axin-APC-beta-catenin-GSK3B complex,T cell differentiation in thymus,anterior/posterior pattern specification,apoptotic process,axis specification,axonal growth cone,axonogenesis,beta-catenin binding,beta-catenin destruction complex,cadherin binding,canonical Wnt receptor signaling pathway,cell adhesion,cell cycle arrest,cell junction,cell migration,cell-cell adherens junction,cellular component disassembly involved in apoptosis,centrosome,chromosome organization,cytokinesis after mitosis,cytoplasm,cytoplasmic microtubule,cytoplasmic microtubule organization,cytoskeleton,cytosol,dorsal/ventral pattern formation,establishment or maintenance of cell polarity,gamma-catenin binding,hair follicle development,kidney development,kinetochore,lamellipodium,lateral plasma membrane,microtubule binding,microtubule plus end,microtubule plus-end binding,mitotic cell cycle spindle assembly checkpoint,mitotic metaphase/anaphase transition,muscle cell homeostasis,negative regulation of MAPKKK cascade,negative regulation of apoptotic process,negative regulation of canonical Wnt receptor signaling pathway,negative regulation of cell proliferation,negative regulation of cyclin-dependent protein kinase activity,negative regulation of epithelial cell proliferation involved in prostate gland development,negative regulation of microtubule depolymerization,negative regulation of odontogenesis,neuron projection development,neuronal cell body,nucleus,pancreas development,plasma membrane,positive regulation of apoptotic process,positive regulation of cell adhesion,positive regulation of cell division,positive regulation of cell migration,positive regulation of epithelial cell differentiation,positive regulation of microtubule polymerization,positive regulation of protein catabolic process,positive regulation of pseudopodium assembly,protein binding,protein complex assembly,protein kinase binding,protein kinase regulator activity,proximal/distal pattern formation,regulation of attachment of spindle microtubules to kinetochore,regulation of cell cycle,regulation of microtubule-based process,regulation of nitrogen compound metabolic process,regulation of osteoblast differentiation,regulation of osteoclast differentiation,response to DNA damage stimulus,response to drug,retina development in camera-type eye,ruffle membrane,skin development,somatic stem cell maintenance,synapse,thymus development,tight junction,tight junction assembly			0.00001	238.774	G=1664, GC=302		G=819/845, GC=262/40	3	
chr5:176517797	T/T	C	SNV		FGFR4	exonic	1								99.00	p.Pro136Leu		1999	C=0.01, T=0.99		Present				+	4	NM_213647.1	c.407C>T	missense	1.12	0.3	98.0	0.0	Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase	rs376618		0.185 (ref)	0.248	0.3393	0.2789	YES	ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process	Palifermin		0.00001	26266.0	C=20, T=1979		C=5/15, T=1264/715	4	
chr5:176517985	A/G	A	SNV		FGFR4	exonic	1								33.25	p.(=)		845	A=0.6675, G=0.3325		Present				+	5	NM_213647.1	c.483A>G	synonymous	-3.74				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,alveolar secondary septum development,cell migration,cell-cell junction,cytoplasm,endoplasmic reticulum,endosome,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor 2 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,glucose homeostasis,heparin binding,insulin receptor signaling pathway,integral to plasma membrane,lung development,nucleolus,nucleotide binding,nucleus,organ induction,peptidyl-tyrosine phosphorylation,phosphate ion homeostasis,plasma membrane,positive regulation of DNA biosynthetic process,positive regulation of ERK1 and ERK2 cascade,positive regulation of cell proliferation,positive regulation of metalloenzyme activity,positive regulation of proteolysis,protein autophosphorylation,protein tyrosine kinase activity,receptor activity,regulation of bile acid biosynthetic process,regulation of cholesterol homeostasis,regulation of extracellular matrix disassembly,regulation of lipid metabolic process	Palifermin		0.00001	1588.71	A=564, G=281		A=303/261, G=269/12	1	
chr6:117638419	T/TG	T	INDEL		ROS1	exonic	1								12.07	p.Asn2008fs		1723	T=0.8793, TG=0.1207		Present				-	38	NM_002944.2	c.6021_6022insC	frameshiftInsertion	2.01				Fibronectin type III domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,cell differentiation,cell growth,cell proliferation,columnar/cuboidal epithelial cell development,integral to membrane,membrane fraction,negative regulation of gene expression,nucleotide binding,plasma membrane,protein phosphatase binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of ERK1 and ERK2 cascade,regulation of TOR signaling cascade,regulation of phosphate transport,spermatogenesis,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway			0.00001	85.6068	T=1515, TG=208		T=671/844, TG=47/161	3	
chr6:117711009, chr6:117632280			ASSAYS_5P_3P		ROS1								ROS1.5p_NM_002944.2.e11e12,ROS1.3p_NM_002944.2.e38e39				109,0				Absent, LOW_5P_3P_IMBALANCE_SCORE	-4.0E-4		4.0286e-10,0.0000																						0.0					
chr7:55221821	G/GC	G	INDEL		EGFR	exonic	1					HS	COSM21686		A=0.00, GC=3.54	p.Thr290fs		1979	G=0.9646, A=0.0, GC=0.0354		Present				+	7	NM_005228.3	c.867_868insC	frameshiftInsertion	2.82				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain								AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.07496	11.2518	G=1909, A=0, GC=70		G=839/1070, A=0/0, GC=66/4	1,2	
chr7:55242460	ATCAAGGAATTAAGAGAAGC/ATCAAGGGAATTAAGAGAAGC	ATCAAGGAATTAAGAGAAGC	INDEL		EGFR	exonic	1					HS	COSM133186;COSM85798		ATCAAGGGAATTAAGAGAAGC=10.89, CTTAAGAGAGC=0.00, GTCAA=0.00	p.Glu746fs		1938	ATCAAGGAATTAAGAGAAGC=0.8911, ATCAAGGGAATTAAGAGAAGC=0.1089, CTTAAGAGAGC=0.0, GTCAA=0.0		Present				+	19	NM_005228.3	c.2236_2237insG	frameshiftInsertion	2.16,2.16,2.68,2.16,2.16,1.4,2.68,0.98,-0.2,0.39,2.07,-1.46,-0.61,2.56,0.07,2.56,2.07,0.39,2.56,2.56				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs121913229,rs121913421,rs121913422,rs121913423,rs121913424,rs121913425,rs121913426,rs121913427,rs121913433,rs121913435,rs121913436,rs121913437,rs121913438,rs121913439,rs121913440,rs121913441,rs121913442							AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	373.951	ATCAAGGAATTAAGAGAAGC=1727, ATCAAGGGAATTAAGAGAAGC=211, CTTAAGAGAGC=0, GTCAA=0		ATCAAGGAATTAAGAGAAGC=1118/609, ATCAAGGGAATTAAGAGAAGC=18/193, CTTAAGAGAGC=0/0, GTCAA=0/0	2,1,1	
chr7:55249063	A/A	G	SNV		EGFR,EGFR-AS1	exonic, exonic_nc	1								100.00	p.(=)		1985	G=0.0, A=1.0		Present				+, -	20	NM_005228.3, NR_047551.1	c.2361G>A	synonymous	2.8				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs1050171		0.418 (ref)	0.3962	0.4226	0.4576	YES	AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	26531.2	G=0, A=1985		G=0/0, A=1109/876	1	
chr7:55259514	CTGG/CTGGG	CTGG	INDEL		EGFR	exonic	1					HS	COSM12366;COSM24268;COSM13553		AAGG=0.00, AGGG=0.00, ATGG=0.00, CTGGC=7.38, CTGGG=8.10	p.Ala859fs		1950	CTGG=0.8451, AAGG=0.0, AGGG=0.0, ATGG=0.0, CTGGC=0.0738, CTGGG=0.081		Present				+	21	NM_005228.3	c.2575_2576insG	frameshiftInsertion	1.42,2.18,2.69,2.75				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain	rs121434568,rs121913443							AP-2 adaptor complex,ATP binding,Golgi apparatus,Golgi membrane,MAP/ERK kinase kinase activity,Shc-EGFR complex,actin filament binding,activation of phospholipase A2 activity by calcium-mediated signaling,activation of phospholipase C activity,axon guidance,basolateral plasma membrane,cell morphogenesis,cell proliferation,cell surface receptor linked signaling pathway,cell-cell adhesion,cerebral cortex cell migration,cytoplasm,digestive tract morphogenesis,double-stranded DNA binding,embryonic placenta development,endocytic vesicle,endoplasmic reticulum,endoplasmic reticulum membrane,endosome,endosome membrane,enzyme binding,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,extracellular region,extracellular space,hair follicle development,identical protein binding,integral to membrane,intracellular,membrane,membrane raft,morphogenesis of an epithelial fold,multicellular organismal development,negative regulation of apoptotic process,negative regulation of epidermal growth factor receptor signaling pathway,negative regulation of protein catabolic process,nitric-oxide synthase regulator activity,nuclear membrane,nucleotide binding,nucleus,ossification,perinuclear region of cytoplasm,plasma membrane,positive regulation of DNA repair,positive regulation of DNA replication,positive regulation of MAP kinase activity,positive regulation of catenin import into nucleus,positive regulation of cell migration,positive regulation of cell proliferation,positive regulation of cyclin-dependent protein kinase activity involved in G1/S,positive regulation of epithelial cell proliferation,positive regulation of fibroblast proliferation,positive regulation of nitric oxide biosynthetic process,positive regulation of phosphorylation,positive regulation of protein kinase B signaling cascade,protein autophosphorylation,protein binding,protein heterodimerization activity,protein insertion into membrane,protein phosphatase binding,protein tyrosine kinase activity,receptor activity,receptor signaling protein tyrosine kinase activity,regulation of nitric-oxide synthase activity,regulation of peptidyl-tyrosine phosphorylation,response to UV-A,response to stress,salivary gland morphogenesis,signal transducer activity,signal transduction,transmembrane receptor protein tyrosine kinase activity,transmembrane signaling receptor activity	Cetuximab,Erlotinib,Flavopiridol,Gefitinib,Lapatinib,Lidocaine,N-4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL-ACRYLAMIDE,Panitumumab,S-{3-(4-ANILINOQUINAZOLIN-6-YL)AMINO-3-OXOPROPYL}-L-CYSTEINE,Trastuzumab,ZD-6474		0.00001	681.062	CTGG=1648, AAGG=0, AGGG=0, ATGG=0, CTGGC=144, CTGGG=158		CTGG=736/912, AAGG=0/0, AGGG=0/0, ATGG=0/0, CTGGC=141/3, CTGGG=19/139	1,1,1,2,2	
chr8:38271504	A/AG	A	INDEL		FGFR1	exonic	1								24.19	p.Ser773fs		1980	A=0.7581, AG=0.2419		Present				-	18	NM_001174067.1	c.2316_2317insC	frameshiftInsertion	1.94				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,MAPKKK cascade,axon guidance,cell migration,chordate embryonic development,cytoplasm,cytoplasmic membrane-bounded vesicle,cytosol,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,heparin binding,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,neuron migration,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of neuron differentiation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of phospholipase activity,protein autophosphorylation,protein binding,protein homodimerization activity,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell differentiation,regulation of transcription, DNA-dependent,skeletal system development,skeletal system morphogenesis	(E)-4-(3,5-difluorophenyl)-3H-pyrrolo2,3-bpyridin-3-ylidene(3-methoxyphenyl)methanol,3-(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE-2-INDOLINONE,3-(3-methoxybenzyl)-1H-pyrrolo2,3-bpyridine,Palifermin,SU4984		0.00001	940.977	A=1501, AG=479		A=792/709, AG=107/372	3	
chr8:38285445	G/GC	G	INDEL		FGFR1	exonic	1								8.82	p.Tyr237fs		1985	G=0.9118, GC=0.0882		Present				-	6	NM_001174067.1	c.707_708insG	frameshiftInsertion	0.68				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,MAPKKK cascade,axon guidance,cell migration,chordate embryonic development,cytoplasm,cytoplasmic membrane-bounded vesicle,cytosol,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,heparin binding,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,neuron migration,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of neuron differentiation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of phospholipase activity,protein autophosphorylation,protein binding,protein homodimerization activity,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell differentiation,regulation of transcription, DNA-dependent,skeletal system development,skeletal system morphogenesis	(E)-4-(3,5-difluorophenyl)-3H-pyrrolo2,3-bpyridin-3-ylidene(3-methoxyphenyl)methanol,3-(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE-2-INDOLINONE,3-(3-methoxybenzyl)-1H-pyrrolo2,3-bpyridine,Palifermin,SU4984		0.00937	20.282	G=1810, GC=175		G=777/1033, GC=105/70	2	
chr8:38285458	T/TG	T	INDEL		FGFR1	exonic	1								11.71	p.His232fs		1989	T=0.8829, TG=0.1171		Present				-	6	NM_001174067.1	c.694_695insC	frameshiftInsertion	2.13				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,MAPKKK cascade,axon guidance,cell migration,chordate embryonic development,cytoplasm,cytoplasmic membrane-bounded vesicle,cytosol,extracellular region,fibroblast growth factor 1 binding,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor-activated receptor activity,heparin binding,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,neuron migration,nucleotide binding,nucleus,peptidyl-tyrosine phosphorylation,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of cell proliferation,positive regulation of neuron differentiation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of phospholipase C activity,positive regulation of phospholipase activity,protein autophosphorylation,protein binding,protein homodimerization activity,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell differentiation,regulation of transcription, DNA-dependent,skeletal system development,skeletal system morphogenesis	(E)-4-(3,5-difluorophenyl)-3H-pyrrolo2,3-bpyridin-3-ylidene(3-methoxyphenyl)methanol,3-(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE-2-INDOLINONE,3-(3-methoxybenzyl)-1H-pyrrolo2,3-bpyridine,Palifermin,SU4984		0.00001	79.2264	T=1756, TG=233		T=855/901, TG=21/212	2	
chr10:43606730, chr10:43622086			ASSAYS_5P_3P		RET								RET.5p_NM_020975.4.e6e7,RET.3p_NM_020975.4.e18e19				609,2285				Absent, LOW_5P_3P_IMBALANCE_SCORE	0.0064		2.2508e-09,8.4452e-09																						0.0					
chr10:43613843	T/T	G	SNV		RET	exonic	1								100.00	p.(=)		1909	G=0.0, T=1.0		Present				+	13	NM_020975.4	c.2307G>T	synonymous	1.34				Cadherin domain,Protein kinase domain,Protein tyrosine kinase	rs1800861		0.277 (ref)	0.2347	0.1246	0.1974	YES	ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib	untested	0.00001	25690.9	G=0, T=1909		G=0/0, T=936/973	1	
chr10:43615633	C/G	C	SNV		RET	exonic	1								41.71	p.(=)		1695	C=0.5829, G=0.4171		Present				+	15	NM_020975.4	c.2712C>G	synonymous	0.73				Cadherin domain,Protein kinase domain,Protein tyrosine kinase	rs1800863		0.16 (ref)	0.1866	0.111	0.1609	YES	ATP binding,MAPKKK cascade,calcium ion binding,cellular response to retinoic acid,embryonic epithelial tube formation,endosome membrane,enteric nervous system development,homophilic cell adhesion,induction of apoptosis,integral to membrane,integral to plasma membrane,membrane,membrane protein proteolysis,nervous system development,neural crest cell migration,neuron maturation,nucleotide binding,positive regulation of cell adhesion mediated by integrin,positive regulation of cell migration,positive regulation of metanephric glomerulus development,positive regulation of neuron projection development,positive regulation of transcription, DNA-dependent,posterior midgut development,protein binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,regulation of cell adhesion,response to pain,signal transduction,transmembrane receptor protein tyrosine kinase activity,ureteric bud development	1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo3,4-DPyrimidin-4-Ylamine,4-BROMO-2-FLUORO-N-(4E)-6-METHOXY-7-(1-METHYLPIPERIDIN-4-YL)METHOXYQUINAZOLIN-4(1H)-YLIDENEANILINE,Imatinib	non-pathogenic	0.00001	4760.08	C=988, G=707		C=457/531, G=324/383	2	
chr10:123247510	T/TG	T	INDEL		FGFR2	exonic	1								9.70	p.Thr661fs		1949	T=0.903, TG=0.097		Present				-	14	NM_000141.4	c.1980_1981insC	frameshiftInsertion	2.06				Immunoglobulin I-set domain,Immunoglobulin V-set domain,Immunoglobulin domain,Protein kinase domain,Protein tyrosine kinase								ATP binding,Golgi apparatus,angiogenesis,apoptotic process,axonogenesis,bone development,bone mineralization,bone morphogenesis,branch elongation involved in salivary gland morphogenesis,branching involved in embryonic placenta morphogenesis,branching involved in prostate gland morphogenesis,branching involved in salivary gland morphogenesis,branching morphogenesis of a nerve,bud elongation involved in lung branching,cell cortex,cell fate commitment,cell surface,cell-cell signaling,cytoplasm,cytoplasmic membrane-bounded vesicle,digestive tract development,embryonic digestive tract morphogenesis,embryonic organ development,embryonic organ morphogenesis,embryonic pattern specification,epidermis morphogenesis,epithelial cell differentiation,epithelial cell proliferation involved in salivary gland morphogenesis,excitatory synapse,extracellular matrix,extracellular region,fibroblast growth factor binding,fibroblast growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,fibroblast growth factor-activated receptor activity,gland morphogenesis,hair follicle morphogenesis,heparin binding,in utero embryonic development,inner ear morphogenesis,insulin receptor signaling pathway,integral to membrane,integral to plasma membrane,lacrimal gland development,lateral sprouting from an epithelium,limb bud formation,lung alveolus development,lung development,lung lobe morphogenesis,lung-associated mesenchyme development,mammary gland bud formation,membrane,membranous septum morphogenesis,mesenchymal cell differentiation,mesenchymal cell differentiation involved in lung development,mesenchymal cell proliferation involved in lung development,midbrain development,morphogenesis of embryonic epithelium,multicellular organism growth,negative regulation of transcription from RNA polymerase II promoter,nucleotide binding,nucleus,odontogenesis,orbitofrontal cortex development,organ growth,organ morphogenesis,otic vesicle formation,outflow tract septum morphogenesis,peptidyl-tyrosine phosphorylation,plasma membrane,positive regulation of ERK1 and ERK2 cascade,positive regulation of MAPKKK cascade,positive regulation of Wnt receptor signaling pathway,positive regulation of canonical Wnt receptor signaling pathway,positive regulation of cardiac muscle cell proliferation,positive regulation of cell cycle,positive regulation of cell division,positive regulation of cell proliferation,positive regulation of epithelial cell proliferation,positive regulation of epithelial cell proliferation involved in lung morphogenesis,positive regulation of mesenchymal cell proliferation,positive regulation of phospholipase activity,positive regulation of transcription from RNA polymerase II promoter,post-embryonic development,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,prostate epithelial cord elongation,prostate gland morphogenesis,protein autophosphorylation,protein binding,protein homodimerization activity,protein tyrosine kinase activity,pyramidal neuron development,receptor activity,regulation of ERK1 and ERK2 cascade,regulation of branching involved in prostate gland morphogenesis,regulation of cell fate commitment,regulation of fibroblast growth factor receptor signaling pathway,regulation of morphogenesis of a branching structure,regulation of multicellular organism growth,regulation of osteoblast differentiation,regulation of osteoblast proliferation,regulation of smooth muscle cell differentiation,regulation of smoothened signaling pathway,reproductive structure development,skeletal system morphogenesis,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,ureteric bud development,ventricular cardiac muscle tissue morphogenesis,ventricular zone neuroblast division	4-4-(1-Amino-1-Methylethyl)Phenyl-5-Chloro-N-4-(2-Morpholin-4-Ylethyl)PhenylPyrimidin-2-Amine,Palifermin,SU4984,Thalidomide		0.00141	28.5128	T=1760, TG=189		T=1103/657, TG=51/138	2	
chr12:56482571	T/TG	T	INDEL		ERBB3	exonic	1								9.92	p.Asp344fs		1986	T=0.9008, TG=0.0992		Present				+	9	NM_001982.3	c.1030_1031insG	frameshiftInsertion	2.32				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain								ATP binding,Schwann cell differentiation,apical plasma membrane,axonogenesis,basolateral plasma membrane,cellular response to insulin stimulus,circadian rhythm,cranial nerve development,endocardial cushion development,extracellular region,extracellular space,growth factor binding,heart development,integral to plasma membrane,lateral plasma membrane,mammary gland involution,negative regulation of cell adhesion,negative regulation of neuron apoptosis,negative regulation of secretion,negative regulation of signal transduction,neuron apoptosis,nucleotide binding,nucleus,odontogenesis,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,plasma membrane,positive regulation of glucose import,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of protein tyrosine kinase activity,postsynaptic membrane,protein binding,protein heterodimerization activity,protein homodimerization activity,protein tyrosine kinase activator activity,protein tyrosine kinase activity,receptor activity,receptor complex,receptor signaling protein tyrosine kinase activity,regulation of cell proliferation,response to drug,signal transduction,skeletal muscle tissue development,tongue development,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,transmembrane signaling receptor activity,wound healing			0.0008	30.9514	T=1789, TG=197		T=871/918, TG=57/140	2	
chr12:58145430	C/CG	C	INDEL		CDK4	exonic	1					HS	COSM363684;COSM1989836		A=0.00, CG=5.85, T=0.00	p.Arg24fs		1984	C=0.9415, A=0.0, CG=0.0585, T=0.0		Present				-	2	NM_000075.3	c.70_71insC	frameshiftInsertion	2.86				Protein kinase domain,Protein tyrosine kinase	rs104894340							ATP binding,G1 phase of mitotic cell cycle,G1/S transition of mitotic cell cycle,S phase of mitotic cell cycle,cell cycle,cell division,chromatin,cyclin-dependent protein kinase activity,cyclin-dependent protein kinase holoenzyme complex,cytoplasm,cytosol,membrane,mitotic cell cycle,nuclear membrane,nucleolus,nucleoplasm,nucleotide binding,nucleus,positive regulation of cell proliferation,positive regulation of fibroblast proliferation,protein binding,protein phosphorylation,regulation of cell cycle,regulation of gene expression,response to drug,signal transduction,transcription factor complex	Flavopiridol,Purvalanol		0.00001	65.8058	C=1868, A=0, CG=116, T=0		C=992/876, A=0/0, CG=25/91, T=0/0	1,3,1	
chr15:66729129	A/AG	A	INDEL		MAP2K1	exonic	1								16.09	p.Glu114fs		1983	A=0.8391, AG=0.1609		Present				+	3	NM_002755.3	c.340_341insG	frameshiftInsertion	-0.37				Protein kinase domain,Protein tyrosine kinase								ATP binding,Golgi apparatus,Golgi inheritance,MAP kinase kinase activity,MAPKKK cascade,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,Ras GTPase binding,Ras protein signal transduction,Toll signaling pathway,activation of MAPK activity,activation of MAPKK activity,axon guidance,axon part,cell cortex,cell cycle arrest,cell motility,cellular component movement,cellular senescence,chemotaxis,cytoplasm,cytoskeleton,cytosol,dendrite cytoplasm,epidermal growth factor receptor signaling pathway,innate immune response,insulin receptor signaling pathway,keratinocyte differentiation,labyrinthine layer development,melanosome transport,microtubule,mitogen-activated protein kinase kinase kinase binding,mitosis,negative regulation of cell proliferation,negative regulation of homotypic cell-cell adhesion,nerve growth factor receptor signaling pathway,neuron differentiation,neuron projection morphogenesis,nucleotide binding,nucleus,perikaryon,perinuclear region of cytoplasm,placenta blood vessel development,plasma membrane,positive regulation of Ras GTPase activity,positive regulation of Ras protein signal transduction,positive regulation of cell differentiation,positive regulation of cell migration,positive regulation of transcription elongation from RNA polymerase II promoter,protein binding,protein kinase activity,protein serine/threonine kinase activity,protein tyrosine kinase activity,receptor signaling protein tyrosine phosphatase activity,regulation of vascular smooth muscle contraction,response to axon injury,response to glucocorticoid stimulus,response to oxidative stress,signal transduction,small GTPase mediated signal transduction,soluble fraction,spindle pole body,stress-activated MAPK cascade,toll-like receptor 1 signaling pathway,toll-like receptor 2 signaling pathway,toll-like receptor 3 signaling pathway,toll-like receptor 4 signaling pathway,toll-like receptor signaling pathway,vesicle transport along microtubule	(5S)-4,5-difluoro-6-(2-fluoro-4-iodophenyl)imino-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide,2-(2-chloro-4-iodophenyl)amino-N-{(2R)-2,3-dihydroxypropyloxy}-3,4-difluorobenzamide,2-(4-ETHYNYL-2-FLUOROPHENYL)AMINO-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE,5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-(2-Fluoro-4-Iodophenyl)AminoBenzamide,K-252a,N-(5-{3,4-difluoro-2-(2-fluoro-4-iodophenyl)aminophenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine,N-{(2R)-2,3-dihydroxypropyloxy}-3,4-difluoro-2-(2-fluoro-4-iodophenyl)aminobenzamide		0.00001	285.277	A=1664, AG=319		A=990/674, AG=79/240	3	
chr17:37881001	T/TG	T	INDEL		ERBB2	exonic	1					HS	COSM26681;COSM12555;COSM303939		TG=5.32, TGGG=0.00, TGGGCTCCCC=0.00, TGTGTGG=0.00	p.Ser779fs		1711	T=0.9468, TG=0.0532, TGGG=0.0, TGGGCTCCCC=0.0, TGTGTGG=0.0		Present				+	20	NM_004448.3	c.2333_2334insG	frameshiftInsertion	2.01				Furin-like cysteine rich region,Protein kinase domain,Protein tyrosine kinase,Receptor L domain								ATP binding,ErbB-3 class receptor binding,Hsp90 protein binding,RNA polymerase I core binding,apical plasma membrane,axon guidance,basal plasma membrane,basolateral plasma membrane,cell proliferation,cell surface receptor linked signaling pathway,cytoplasm,endosome membrane,enzyme linked receptor protein signaling pathway,epidermal growth factor receptor signaling pathway,epidermal growth factor-activated receptor activity,estrus,glial cell differentiation,glycoprotein binding,growth factor binding,heart development,identical protein binding,integral to membrane,lateral loop,liver development,mammary gland development,mammary gland involution,membrane raft,microvillus,motor axon guidance,myelination,negative regulation of apoptotic process,negative regulation of immature T cell proliferation in thymus,nervous system development,neuromuscular junction development,nucleotide binding,nucleus,perinuclear region of cytoplasm,peripheral nervous system development,phosphatidylinositol 3-kinase cascade,phosphatidylinositol-mediated signaling,plasma membrane,positive regulation of MAP kinase activity,positive regulation of MAPKKK cascade,positive regulation of Ras protein signal transduction,positive regulation of cell adhesion,positive regulation of cell growth,positive regulation of epithelial cell proliferation,positive regulation of phosphatidylinositol 3-kinase cascade,positive regulation of transcription from RNA polymerase I promoter,positive regulation of transcription from RNA polymerase III promoter,positive regulation of translation,postsynaptic membrane,protein C-terminus binding,protein autophosphorylation,protein binding,protein dimerization activity,protein heterodimerization activity,protein phosphatase binding,protein phosphorylation,protein tyrosine kinase activity,receptor activity,receptor complex,receptor signaling protein tyrosine kinase activity,regulation of ERK1 and ERK2 cascade,regulation of angiogenesis,regulation of microtubule-based process,regulation of transcription, DNA-dependent,response to axon injury,response to drug,response to progesterone stimulus,signal transduction,skeletal muscle tissue development,sympathetic nervous system development,tongue development,transmembrane receptor protein tyrosine kinase activity,transmembrane receptor protein tyrosine kinase signaling pathway,transmembrane signaling receptor activity,ubiquitin protein ligase binding,wound healing	Lapatinib,Trastuzumab		0.00059	32.3134	T=1620, TG=91, TGGG=0, TGGGCTCCCC=0, TGTGTGG=0		T=874/746, TG=29/62, TGGG=0/0, TGGGCTCCCC=0/0, TGTGTGG=0/0	3,3,3,3	
